146 related articles for article (PubMed ID: 11818323)
1. Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation.
Liaudet L; Pacher P; Mabley JG; Virág L; Soriano FG; Haskó G; Szabó C
Am J Respir Crit Care Med; 2002 Feb; 165(3):372-7. PubMed ID: 11818323
[TBL] [Abstract][Full Text] [Related]
2. Integrin-mediated suppression of endotoxin-induced DNA damage in lung endothelial cells is sensitive to poly(ADP-ribose) polymerase-1 gene deletion.
Huang H; McIntosh JL; Fang L; Szabo C; Hoyt DG
Int J Mol Med; 2003 Oct; 12(4):533-40. PubMed ID: 12964031
[TBL] [Abstract][Full Text] [Related]
3. The role of poly(ADP-ribose) polymerase-1 inhibitor in carrageenan-induced lung inflammation in mice.
Ahmad SF; Zoheir KM; Ansari MA; Korashy HM; Bakheet SA; Ashour AE; Al-Shabanah OA; Al-harbi MM; Attia SM
Mol Immunol; 2015 Feb; 63(2):394-405. PubMed ID: 25304310
[TBL] [Abstract][Full Text] [Related]
4. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and the development of bleomycin-induced lung injury.
Genovese T; Mazzon E; Di Paola R; Muià C; Threadgill MD; Caputi AP; Thiemermann C; Cuzzocrea S
J Pharmacol Exp Ther; 2005 May; 313(2):529-38. PubMed ID: 15644425
[TBL] [Abstract][Full Text] [Related]
5. Effects of poly(ADP-ribose) polymerase inhibition on inflammatory cell migration in a murine model of asthma.
Virág L; Bai P; Bak I; Pacher P; Mabley JG; Liaudet L; Bakondi E; Gergely P; Kollai M; Szabó C
Med Sci Monit; 2004 Mar; 10(3):BR77-83. PubMed ID: 14976461
[TBL] [Abstract][Full Text] [Related]
6. Role of PARP on iNOS pathway during endotoxin-induced acute lung injury.
Kiefmann R; Heckel K; Doerger M; Schenkat S; Kupatt C; Stoeckelhuber M; Wesierska-Gadek J; Goetz AE
Intensive Care Med; 2004 Jul; 30(7):1421-31. PubMed ID: 15197441
[TBL] [Abstract][Full Text] [Related]
7. Role of poly-(ADP-ribose) synthetase in lipopolysaccharide-induced vascular failure and acute lung injury in pigs.
Albertini M; Clement MG; Lafortuna CL; Caniatti M; Magder S; Abdulmalek K; Hussain SN
J Crit Care; 2000 Jun; 15(2):73-83. PubMed ID: 10877368
[TBL] [Abstract][Full Text] [Related]
8. Niacinamide abrogates the organ dysfunction and acute lung injury caused by endotoxin.
Kao SJ; Liu DD; Su CF; Chen HI
J Cardiovasc Pharmacol; 2007 Sep; 50(3):333-42. PubMed ID: 17878764
[TBL] [Abstract][Full Text] [Related]
9. Regulation of kinase cascades and transcription factors by a poly(ADP-ribose) polymerase-1 inhibitor, 4-hydroxyquinazoline, in lipopolysaccharide-induced inflammation in mice.
Veres B; Radnai B; Gallyas F; Varbiro G; Berente Z; Osz E; Sumegi B
J Pharmacol Exp Ther; 2004 Jul; 310(1):247-55. PubMed ID: 14999056
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of poly (adenosine diphosphate-ribose) polymerase attenuates lung-kidney crosstalk induced by intratracheal lipopolysaccharide instillation in rats.
Si MK; Mitaka C; Tulafu M; Abe S; Kitagawa M; Ikeda S; Eishi Y; Kurata S; Tomita M
Respir Res; 2013 Nov; 14(1):126. PubMed ID: 24229378
[TBL] [Abstract][Full Text] [Related]
11. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of poly (ADP-ribose) polymerase attenuates acute lung injury in an ovine model of sepsis.
Murakami K; Enkhbaatar P; Shimoda K; Cox RA; Burke AS; Hawkins HK; Traber LD; Schmalstieg FC; Salzman AL; Mabley JG; Komjáti K; Pacher P; Zsengellér Z; Szabó C; Traber DL
Shock; 2004 Feb; 21(2):126-33. PubMed ID: 14752285
[TBL] [Abstract][Full Text] [Related]
13. TRPM2 channels in alveolar epithelial cells mediate bleomycin-induced lung inflammation.
Yonezawa R; Yamamoto S; Takenaka M; Kage Y; Negoro T; Toda T; Ohbayashi M; Numata T; Nakano Y; Yamamoto T; Mori Y; Ishii M; Shimizu S
Free Radic Biol Med; 2016 Jan; 90():101-13. PubMed ID: 26600069
[TBL] [Abstract][Full Text] [Related]
14. Poly (ADP-ribose) polymerase-1 inhibitor, 3-aminobenzamide pretreatment ameliorates lipopolysaccharide-induced neurobehavioral and neurochemical anomalies in mice.
Sriram CS; Jangra A; Gurjar SS; Hussain MI; Borah P; Lahkar M; Mohan P; Bezbaruah BK
Pharmacol Biochem Behav; 2015 Jun; 133():83-91. PubMed ID: 25863272
[TBL] [Abstract][Full Text] [Related]
15. Tempol, a membrane-permeable radical scavenger, ameliorates lipopolysaccharide-induced acute lung injury in mice: a key role for superoxide anion.
El-Sayed NS; Mahran LG; Khattab MM
Eur J Pharmacol; 2011 Aug; 663(1-3):68-73. PubMed ID: 21554869
[TBL] [Abstract][Full Text] [Related]
16. Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure.
Pacher P; Liaudet L; Bai P; Virag L; Mabley JG; Haskó G; Szabó C
J Pharmacol Exp Ther; 2002 Mar; 300(3):862-7. PubMed ID: 11861791
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma.
Genovese T; Mazzon E; Muià C; Patel NS; Threadgill MD; Bramanti P; De Sarro A; Thiemermann C; Cuzzocrea S
J Pharmacol Exp Ther; 2005 Feb; 312(2):449-57. PubMed ID: 15452194
[TBL] [Abstract][Full Text] [Related]
18. Purines inhibit poly(ADP-ribose) polymerase activation and modulate oxidant-induced cell death.
Virág L; Szabó C
FASEB J; 2001 Jan; 15(1):99-107. PubMed ID: 11149897
[TBL] [Abstract][Full Text] [Related]
19. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of acute pulmonary and systemic inflammation by 1,7-dimethylxanthine.
Geraets L; Haegens A; Weseler AR; Brauers K; Vernooy JH; Wouters EF; Bast A; Hageman GJ
Eur J Pharmacol; 2010 Mar; 629(1-3):132-9. PubMed ID: 19962977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
